Team:USTC CHINA/Project/Results
From 2013.igem.org
(Difference between revisions)
Line 71: | Line 71: | ||
<div><p>① E.coli BL21 proved that the standard transdermal locus does work with GFP.</p></div> | <div><p>① E.coli BL21 proved that the standard transdermal locus does work with GFP.</p></div> | ||
+ | <div><p>***这里有一张线路图,@一只邵雪盈****</p></div> | ||
+ | <div><p>Using GFP to prove the validity of a newly designed circuit is a classical way to verify the expressing of this circuit. As expressions in E.coli involve neither secretory nor sequential problems, we hoped to verify the practicality of our locus by the expression of TD1-GFP. Thus we selected pET22b,which is a common recombinant vector for plasmid construction, as our recombinant vector and E.coli BL21 as engineered bacteria . We fused sequence TD1-GFP with T7 promoter from pET22b downstream and succeeded in expressing fusion protein TD1-GFP, induced by IPTG. </p></div> | ||
+ | |||
<div><p>② The expression of recombinant antigen and adjuvant in E.coli BL21.</p></div> | <div><p>② The expression of recombinant antigen and adjuvant in E.coli BL21.</p></div> | ||
<div><p>③ ELISA验证重组抗原TD1-HBsAg具有抗原性.</p></div> | <div><p>③ ELISA验证重组抗原TD1-HBsAg具有抗原性.</p></div> |
Revision as of 00:29, 26 September 2013